Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/OMI · Entity 6858 | EVP, CFO | June 03, 2024 | June 04, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date June 03, 2024 · Filed June 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 49,950 |
Reported balance
After 2024-06-03 transaction · row 1
1 source rowRow 1 · 2024-06-03 · Sale · Disposed 10,568 · Balance 49,950 F1: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 1, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2024 Filed Jun 4, 2024 22:07 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 10,568 | $17.76 | $187,687.68 |
DisclosureSEC source: 0001062993-24-011893 · form4.xml · nonDerivative · entry 1 Bruni Alexander J · CIK 0001949360 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,950 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 1, 2024. Read SEC document |
| May 15, 2024 Filed May 16, 2024 20:58 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 5,290 | $19.78 | $104,636.20 |
DisclosureSEC source: 0001062993-24-010493 · form4.xml · nonDerivative · entry 1 Bruni Alexander J · CIK 0001949360 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,518 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:48 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 24,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005528 · form4.xml · nonDerivative · entry 1 Bruni Alexander J · CIK 0001949360 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,808 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| November 10, 2023 Filed Nov 14, 2023 00:02 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 12,668 | $17.57 | $222,576.76 |
DisclosureSEC source: 0001062993-23-020715 · form4.xml · nonDerivative · entry 1 Bruni Alexander J · CIK 0001949360 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,457 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 8, 2023. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 20:02 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 328 | $19.63 | $6,438.64 |
DisclosureSEC source: 0001062993-23-016598 · form4.xml · nonDerivative · entry 1 Bruni Alexander J · CIK 0001949360 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,125 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:04 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 1,641 | $18.73 | $30,735.93 |
DisclosureSEC source: 0001062993-23-011353 · form4.xml · nonDerivative · entry 1 Bruni Alexander J · CIK 0001949360 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,453 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| May 11, 2023 Filed May 12, 2023 13:05 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 3,219 | $18.39 | $59,197.41 |
DisclosureSEC source: 0001062993-23-010879 · form4.xml · nonDerivative · entry 1 Bruni Alexander J · CIK 0001949360 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,094 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 12:59 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 32,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005696 · form4.xml · nonDerivative · entry 1 Bruni Alexander J · CIK 0001949360 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,313 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.